Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAD+ in Brain Aging and Neurodegenerative Disorders
Sofie Lautrup, David Sinclair, Mark P. Mattson, et al.
Cell Metabolism (2019) Vol. 30, Iss. 4, pp. 630-655
Open Access | Times Cited: 560

Showing 1-25 of 560 citing articles:

NAD+ metabolism and its roles in cellular processes during ageing
Anthony J. Covarrubias, Rosalba Perrone, Alessia Grozio, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 22, Iss. 2, pp. 119-141
Open Access | Times Cited: 958
Autophagy in healthy aging and disease
Yahyah Aman, Tomas Schmauck‐Medina, Malene Hansen, et al.
Nature Aging (2021) Vol. 1, Iss. 8, pp. 634-650
Open Access | Times Cited: 885
Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 801
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 700
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie, Lu Zhang, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 653
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
Evandro Fei Fang, Chenglong Xie, Joseph Adam Schenkel, et al.
Ageing Research Reviews (2020) Vol. 64, pp. 101174-101174
Open Access | Times Cited: 448
Molecular mechanisms and consequences of mitochondrial permeability transition
Massimo Bonora, Carlotta Giorgi, Paolo Pinton
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 4, pp. 266-285
Closed Access | Times Cited: 347
The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 243
New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary
Tomas Schmauck‐Medina, Adrian Molière, Sofie Lautrup, et al.
Aging (2022) Vol. 14, Iss. 16, pp. 6829-6839
Open Access | Times Cited: 229
Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives
Zhigang Zhang, Xifei Yang, You‐Qiang Song, et al.
Ageing Research Reviews (2021) Vol. 72, pp. 101464-101464
Open Access | Times Cited: 225
NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome
Evandro Fei Fang, Yujun Hou, Sofie Lautrup, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 219
Role of NAD+ in regulating cellular and metabolic signaling pathways
Sara Amjad, Sabah Nisar, Ajaz A. Bhat, et al.
Molecular Metabolism (2021) Vol. 49, pp. 101195-101195
Open Access | Times Cited: 215
Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow
Chenglong Xie, Xu‐Xu Zhuang, Zhangming Niu, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 1, pp. 76-93
Open Access | Times Cited: 212
NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway
Yao Zhao, Jiawei Zhang, Yaling Zheng, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 201
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
Brage Brakedal, Christian Dölle, Frank Riemer, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 396-407.e6
Open Access | Times Cited: 194
Mitophagy in human health, ageing and disease
Anna Picca, Julie Faitg, Johan Auwerx, et al.
Nature Metabolism (2023) Vol. 5, Iss. 12, pp. 2047-2061
Closed Access | Times Cited: 181
Aging - Oxidative stress, antioxidants and computational modeling
Umm-e-Ammara Warraich, Fatma Hussain, Haroon Ur Rashid Kayani
Heliyon (2020) Vol. 6, Iss. 5, pp. e04107-e04107
Open Access | Times Cited: 169
Evolving concepts in NAD+ metabolism
Claudia C.S. Chini, Julianna D. Zeidler, Sonu Kashyap, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1076-1087
Open Access | Times Cited: 169
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases
Jie Li, Dongming Yang, Zhiping Li, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101817-101817
Closed Access | Times Cited: 145
Neurogenesis in aging and age-related neurodegenerative diseases
Luka Čulig, Xixia Chu, Vilhelm A. Bohr
Ageing Research Reviews (2022) Vol. 78, pp. 101636-101636
Open Access | Times Cited: 117
Mitochondrial heterogeneity and homeostasis through the lens of a neuron
Gülçin Pekkurnaz, Xinnan Wang
Nature Metabolism (2022) Vol. 4, Iss. 7, pp. 802-812
Closed Access | Times Cited: 115
Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer’s disease
Larissa Traxler, Joseph R. Herdy, Davide Stefanoni, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1248-1263.e6
Open Access | Times Cited: 106
Mitochondria: It is all about energy
Amaloha Casanova, Anne Wevers, Santiago Navarro‐Ledesma, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 105
An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease
Victor Lau, Leanne M. Ramer, Marie‐Ève Tremblay
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 96
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top